ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03366142
Brief Title: Ustekinumab (Anti-IL-12/23p40 Monoclonal Antibody) in Patients With Leukocyte Adhesion Deficiency Type 1 (LAD1) Who Have Inflammatory Pathology

First Submitted : December 7, 2017
First Submitted that Met QC Criteria : December 7, 2017
First Posted : December 8, 2017

Last Update Submitted that Met QC Criteria : June 20, 2018
Last Update Posted : June 21, 2018 (Estimate)